vialroom

#tirzepatide 2026-02-26

Thursday55 messages13 participantstimes are UTC
Highlights from this day
  • private_script_pri — my PeptideMeter result on a GL Biochem vial came in at 96.8 which is why i keep buying from them 15:02
  • surpass_two — i sat at 7.5 for 20 months and never needed more, which is where the folklore comes from 15:37
  • VialBot — Batch lookup F-1330: 7 independent reports on file, earliest 2025-06-20. 16:22
  • mira_pins — GI was noticeably easier for me than semaglutide at what felt like the same appetite effect, ymmv 17:07
  • VialBot — Batch lookup B-0329: 2 independent reports on file, earliest 2025-10-28. 20:00

is 7.5 really the sweet spot or is that just channel folklore

the sweet spot argument is really about effect per side effect, not a magic number

im at 15 and thinking about 1.7, did anyone gain anything from that step

SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up, your mileage will differ

if youre coming off semaglutide the honest answer is start low and find out, theres no table

[edited]

anyone got a 8 recon they like for the 30 vials

40 units of a 2 solution is a lot of volume and i check that one twice every single time, someone check my working

my PeptideMeter result on a GL Biochem vial came in at 96.8 which is why i keep buying from them

WT

i argued the sweet spot was nonsense and then spent 12 months at 7.5 not needing more

ST

12 did nothing extra over 10 for me and that still holds a year later

is the 2 vial the common one or do people use 40

OW

went back to semaglutide after 23 months because the cost difference mattered more than the GI

ST

i sat at 7.5 for 20 months and never needed more, which is where the folklore comes from

🧪7🤝2

at 0.25 my appetite is gone entirely, did anyone go down rather than up

OW

i log everything and my appetite curve looks flatter across the week than my semaglutide log did, i could be wrong

PM

no gap when i switched, took the last semaglutide dose and started this a week later

PM

for the archive dual agonist, GIP as well as GLP-1, thats the whole difference in one line

VB

Batch lookup F-1330: 7 independent reports on file, earliest 2025-06-20.

PM

plateaued at 23 weeks the same way i did on semaglutide, so i doubt its compound specific

WT

the 40 vial in 0.5ml gives 2mg/ml which puts 0.25 on 10 units, nice round numbers

📈2

SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted

GI was noticeably easier for me than semaglutide at what felt like the same appetite effect, ymmv

Cited study
Tirzepatide for Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA)
New England Journal of Medicine · 2024
AHI as the primary endpoint, with and without PAP therapy.
MP

licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does

TT

the 2.5 to 5 step was the roughest one for me and everything after was easier, still working it out

MP

the two compounds arent interchangeable week for week even if the effect ends up similar, for what its worth

👍1
VB

Batch lookup B-0329: 9 independent reports on file, earliest 2026-01-25.

VB

Inter-lab diff for lot H-2814: 99% vs 96.8%. Within expected range.

BS

quick one i went to 15 and came back to 10, more suppression wasnt more useful for me

5 was where i first noticed it properly, 2.5 did almost nothing for me

BS

restarted at 2.5 after 15 months off and the first two doses reminded me why titration exists, from memory

at 15 the GI came back for me, so my easier profile claim only applies below that

VB

Batch lookup B-0329: 2 independent reports on file, earliest 2025-10-28.

🎉5

the GIP explanation for easier nausea is plausible and i still treat it as a story not a fact

held 10 for 13 months and lost 5kg over that stretch, slow and boring and fine, your mileage will differ

coming off semaglutide, is there a conversion or do i restart at 2.5

anyone stopped at 10 and stayed there for months

MP

changed my mind about needing 15, i was chasing a number rather than an outcome